 | • レポートコード：D0GIR-01326 • 出版社/出版日：GlobalInfoResearch / 2020年9月23日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、109ページ • 納品方法：Eメール • 産業分類：医療、製薬、バイオ |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、薬剤・ワクチン臨床試験の世界市場を広く調査・分析し、今後の市場展望をまとめております。薬剤・ワクチン臨床試験の種類別市場規模（フェーズI、フェーズII、フェーズIII、フェーズIV）、用途別市場規模（製薬産業、病院、研究所、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェアなどの情報を掲載しています。 ・市場概要 ・企業情報（販売量、市場シェア、製品概要、SWOT分析）：Quintiles IMS、PRA Health Sciences、ICON Plc、Paraxel International Corporation、Wuxi AppTec Inc.、Charles River Laboratories、INC Research、Pharmaceutical Product Development, LLC、SGS SA、Chiltern International Ltd. ・地域別グローバル市場分析 2015年-2020年 ・薬剤・ワクチン臨床試験の北米市場（アメリカ、カナダ、メキシコ） ・薬剤・ワクチン臨床試験のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・薬剤・ワクチン臨床試験のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・薬剤・ワクチン臨床試験の南米市場（ブラジル、アルゼンチン） ・薬剤・ワクチン臨床試験の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：フェーズI、フェーズII、フェーズIII、フェーズIV ・用途別分析：製薬産業、病院、研究所、その他 ・地域別市場規模予測 2021年-2025年 ・調査の結果・結論 |
Market Overview
The Clinical Trials of Drugs and Vaccines market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
The most likely (base case) scenario is that the global Clinical Trials of Drugs and Vaccines sales will be xx in 2020 from Clinical Trials of Drugs and Vaccines million in 2019, with a change xx% between 2019 and 2020. In addition, based on the latest study, it is to predict that the Covid-19 will be under control in key countries like the United States, Western Europe, East Asia, by the end of Q2 (June), and will resume normal production in Q3 and Q4, the global Clinical Trials of Drugs and Vaccines market size is expected to grow at xx% or more annually for the next five years.
This report also researches and evaluates the impact of Covid-19 outbreak on the Clinical Trials of Drugs and Vaccines industry, involving potential opportunity and challenges, drivers and risks. We present the impact assessment of Covid-19 effects on Clinical Trials of Drugs and Vaccines and market growth forecast based on different scenario (optimistic, pessimistic, very optimistic, most likely etc.).
Market segmentation
Clinical Trials of Drugs and Vaccines market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Clinical Trials of Drugs and Vaccines market has been segmented into:
Phase I
Phase II
Phase III
Phase IV
By Application, Clinical Trials of Drugs and Vaccines has been segmented into:
Pharmaceutical Industry
Hospital
Laboratory
Other
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Clinical Trials of Drugs and Vaccines market presented in the report. This section sheds light on the sales growth of different regional and country-level Clinical Trials of Drugs and Vaccines markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Clinical Trials of Drugs and Vaccines market.
The report offers in-depth assessment of the growth and other aspects of the Clinical Trials of Drugs and Vaccines market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Competitive Landscape and Clinical Trials of Drugs and Vaccines Market Share Analysis
Clinical Trials of Drugs and Vaccines competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Clinical Trials of Drugs and Vaccines sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Clinical Trials of Drugs and Vaccines sales, revenue and market share for each player covered in this report.
The major players covered in Clinical Trials of Drugs and Vaccines are:
Quintiles IMS
PRA Health Sciences
ICON Plc
Paraxel International Corporation
Wuxi AppTec Inc.
Charles River Laboratories
INC Research
Pharmaceutical Product Development, LLC
SGS SA
Chiltern International Ltd.
Among other players domestic and global, Clinical Trials of Drugs and Vaccines market share data is available for global, North America, Europe, Asia-Pacific, Middle East & Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
1 Clinical Trials of Drugs and Vaccines Market Overview
1.1 Product Overview and Scope of Clinical Trials of Drugs and Vaccines
1.2 Classification of Clinical Trials of Drugs and Vaccines by Type
1.2.1 Global Clinical Trials of Drugs and Vaccines Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Clinical Trials of Drugs and Vaccines Revenue Market Share by Type in 2019
1.2.3 Phase I
1.2.4 Phase II
1.2.5 Phase III
1.2.6 Phase IV
1.3 Global Clinical Trials of Drugs and Vaccines Market by Application
1.3.1 Overview: Global Clinical Trials of Drugs and Vaccines Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Pharmaceutical Industry
1.3.3 Hospital
1.3.4 Laboratory
1.3.5 Other
1.4 Global Clinical Trials of Drugs and Vaccines Market by Regions
1.4.1 Global Clinical Trials of Drugs and Vaccines Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Clinical Trials of Drugs and Vaccines (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Clinical Trials of Drugs and Vaccines Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Clinical Trials of Drugs and Vaccines Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Clinical Trials of Drugs and Vaccines Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Clinical Trials of Drugs and Vaccines Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Clinical Trials of Drugs and Vaccines Status and Prospect (2015-2025)
1.5 COVID-19 Outbreak: Clinical Trials of Drugs and Vaccines Industry Impact
1.5.1 COVID-19 Potential Implications for the Clinical Trials of Drugs and Vaccines
1.5.1.1 Scenario One: Very Optimistic: COVID-19 has No Influence on Clinical Trials of Drugs and Vaccines
1.5.1.2 Scenario Two: Optimistic: COVID-19 Will Be Under Control by the End of April
1.5.1.3 Scenario Three: Gloomy: COVID-19 Will Be Under Control Between Q3 and Q4
1.5.1.4 Scenario Four: Most Likely: COVID-19 Will Be Under Control by the End of Q2
1.5.2 Opportunity Analysis in Covid-19 Crisis
1.5.3 Market Risk and Restraints
1.5.4 Market Driving Force
2 Company Profiles
2.1 Quintiles IMS
2.1.1 Quintiles IMS Details
2.1.2 Quintiles IMS Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Quintiles IMS SWOT Analysis
2.1.4 Quintiles IMS Product and Services
2.1.5 Quintiles IMS Clinical Trials of Drugs and Vaccines Revenue, Gross Margin and Market Share (2018-2019)
2.2 PRA Health Sciences
2.2.1 PRA Health Sciences Details
2.2.2 PRA Health Sciences Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 PRA Health Sciences SWOT Analysis
2.2.4 PRA Health Sciences Product and Services
2.2.5 PRA Health Sciences Clinical Trials of Drugs and Vaccines Revenue, Gross Margin and Market Share (2018-2019)
2.3 ICON Plc
2.3.1 ICON Plc Details
2.3.2 ICON Plc Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 ICON Plc SWOT Analysis
2.3.4 ICON Plc Product and Services
2.3.5 ICON Plc Clinical Trials of Drugs and Vaccines Revenue, Gross Margin and Market Share (2018-2019)
2.4 Paraxel International Corporation
2.4.1 Paraxel International Corporation Details
2.4.2 Paraxel International Corporation Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Paraxel International Corporation SWOT Analysis
2.4.4 Paraxel International Corporation Product and Services
2.4.5 Paraxel International Corporation Clinical Trials of Drugs and Vaccines Revenue, Gross Margin and Market Share (2018-2019)
2.5 Wuxi AppTec Inc.
2.5.1 Wuxi AppTec Inc. Details
2.5.2 Wuxi AppTec Inc. Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Wuxi AppTec Inc. SWOT Analysis
2.5.4 Wuxi AppTec Inc. Product and Services
2.5.5 Wuxi AppTec Inc. Clinical Trials of Drugs and Vaccines Revenue, Gross Margin and Market Share (2018-2019)
2.6 Charles River Laboratories
2.6.1 Charles River Laboratories Details
2.6.2 Charles River Laboratories Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Charles River Laboratories SWOT Analysis
2.6.4 Charles River Laboratories Product and Services
2.6.5 Charles River Laboratories Clinical Trials of Drugs and Vaccines Revenue, Gross Margin and Market Share (2018-2019)
2.7 INC Research
2.7.1 INC Research Details
2.7.2 INC Research Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 INC Research SWOT Analysis
2.7.4 INC Research Product and Services
2.7.5 INC Research Clinical Trials of Drugs and Vaccines Revenue, Gross Margin and Market Share (2018-2019)
2.8 Pharmaceutical Product Development, LLC
2.8.1 Pharmaceutical Product Development, LLC Details
2.8.2 Pharmaceutical Product Development, LLC Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Pharmaceutical Product Development, LLC SWOT Analysis
2.8.4 Pharmaceutical Product Development, LLC Product and Services
2.8.5 Pharmaceutical Product Development, LLC Clinical Trials of Drugs and Vaccines Revenue, Gross Margin and Market Share (2018-2019)
2.9 SGS SA
2.9.1 SGS SA Details
2.9.2 SGS SA Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 SGS SA SWOT Analysis
2.9.4 SGS SA Product and Services
2.9.5 SGS SA Clinical Trials of Drugs and Vaccines Revenue, Gross Margin and Market Share (2018-2019)
2.10 Chiltern International Ltd.
2.10.1 Chiltern International Ltd. Details
2.10.2 Chiltern International Ltd. Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Chiltern International Ltd. SWOT Analysis
2.10.4 Chiltern International Ltd. Product and Services
2.10.5 Chiltern International Ltd. Clinical Trials of Drugs and Vaccines Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Clinical Trials of Drugs and Vaccines Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Clinical Trials of Drugs and Vaccines Players Market Share
3.2.2 Top 10 Clinical Trials of Drugs and Vaccines Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Clinical Trials of Drugs and Vaccines Revenue and Market Share by Regions
4.2 North America Clinical Trials of Drugs and Vaccines Revenue and Growth Rate (2015-2020)
4.3 Europe Clinical Trials of Drugs and Vaccines Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Clinical Trials of Drugs and Vaccines Revenue and Growth Rate (2015-2020)
4.5 South America Clinical Trials of Drugs and Vaccines Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Clinical Trials of Drugs and Vaccines Revenue and Growth Rate (2015-2020)
5 North America Clinical Trials of Drugs and Vaccines Revenue by Countries
5.1 North America Clinical Trials of Drugs and Vaccines Revenue by Countries (2015-2020)
5.2 USA Clinical Trials of Drugs and Vaccines Revenue and Growth Rate (2015-2020)
5.3 Canada Clinical Trials of Drugs and Vaccines Revenue and Growth Rate (2015-2020)
5.4 Mexico Clinical Trials of Drugs and Vaccines Revenue and Growth Rate (2015-2020)
6 Europe Clinical Trials of Drugs and Vaccines Revenue by Countries
6.1 Europe Clinical Trials of Drugs and Vaccines Revenue by Countries (2015-2020)
6.2 Germany Clinical Trials of Drugs and Vaccines Revenue and Growth Rate (2015-2020)
6.3 UK Clinical Trials of Drugs and Vaccines Revenue and Growth Rate (2015-2020)
6.4 France Clinical Trials of Drugs and Vaccines Revenue and Growth Rate (2015-2020)
6.5 Russia Clinical Trials of Drugs and Vaccines Revenue and Growth Rate (2015-2020)
6.6 Italy Clinical Trials of Drugs and Vaccines Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Clinical Trials of Drugs and Vaccines Revenue by Countries
7.1 Asia-Pacific Clinical Trials of Drugs and Vaccines Revenue by Countries (2015-2020)
7.2 China Clinical Trials of Drugs and Vaccines Revenue and Growth Rate (2015-2020)
7.3 Japan Clinical Trials of Drugs and Vaccines Revenue and Growth Rate (2015-2020)
7.4 Korea Clinical Trials of Drugs and Vaccines Revenue and Growth Rate (2015-2020)
7.5 India Clinical Trials of Drugs and Vaccines Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Clinical Trials of Drugs and Vaccines Revenue and Growth Rate (2015-2020)
8 South America Clinical Trials of Drugs and Vaccines Revenue by Countries
8.1 South America Clinical Trials of Drugs and Vaccines Revenue by Countries (2015-2020)
8.2 Brazil Clinical Trials of Drugs and Vaccines Revenue and Growth Rate (2015-2020)
8.3 Argentina Clinical Trials of Drugs and Vaccines Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Clinical Trials of Drugs and Vaccines by Countries
9.1 Middle East & Africa Clinical Trials of Drugs and Vaccines Revenue by Countries (2015-2020)
9.2 Saudi Arabia Clinical Trials of Drugs and Vaccines Revenue and Growth Rate (2015-2020)
9.3 UAE Clinical Trials of Drugs and Vaccines Revenue and Growth Rate (2015-2020)
9.4 Egypt Clinical Trials of Drugs and Vaccines Revenue and Growth Rate (2015-2020)
9.5 South Africa Clinical Trials of Drugs and Vaccines Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Clinical Trials of Drugs and Vaccines Revenue and Market Share by Type (2015-2020)
10.2 Global Clinical Trials of Drugs and Vaccines Market Forecast by Type (2019-2024)
10.3 Phase I Revenue Growth Rate (2015-2025)
10.4 Phase II Revenue Growth Rate (2015-2025)
10.5 Phase III Revenue Growth Rate (2015-2025)
10.6 Phase IV Revenue Growth Rate (2015-2025)
11 Global Clinical Trials of Drugs and Vaccines Market Segment by Application
11.1 Global Clinical Trials of Drugs and Vaccines Revenue Market Share by Application (2015-2020)
11.2 Clinical Trials of Drugs and Vaccines Market Forecast by Application (2019-2024)
11.3 Pharmaceutical Industry Revenue Growth (2015-2020)
11.4 Hospital Revenue Growth (2015-2020)
11.5 Laboratory Revenue Growth (2015-2020)
11.6 Other Revenue Growth (2015-2020)
12 Global Clinical Trials of Drugs and Vaccines Market Size Forecast (2021-2025)
12.1 Global Clinical Trials of Drugs and Vaccines Market Size Forecast (2021-2025)
12.2 Global Clinical Trials of Drugs and Vaccines Market Forecast by Regions (2021-2025)
12.3 North America Clinical Trials of Drugs and Vaccines Revenue Market Forecast (2021-2025)
12.4 Europe Clinical Trials of Drugs and Vaccines Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Clinical Trials of Drugs and Vaccines Revenue Market Forecast (2021-2025)
12.6 South America Clinical Trials of Drugs and Vaccines Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Clinical Trials of Drugs and Vaccines Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US
Table 1. Global Clinical Trials of Drugs and Vaccines Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Clinical Trials of Drugs and Vaccines by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Clinical Trials of Drugs and Vaccines Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Clinical Trials of Drugs and Vaccines Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Global Clinical Trials of Drugs and Vaccines Market Size and Growth Estimation in Various Scenarios in 2020
Table 6. Quintiles IMS Corporate Information, Location and Competitors
Table 7. Quintiles IMS Clinical Trials of Drugs and Vaccines Major Business
Table 8. Quintiles IMS Clinical Trials of Drugs and Vaccines Total Revenue (USD Million) (2017-2018)
Table 9. Quintiles IMS SWOT Analysis
Table 10. Quintiles IMS Clinical Trials of Drugs and Vaccines Product and Solutions
Table 11. Quintiles IMS Clinical Trials of Drugs and Vaccines Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 12. PRA Health Sciences Corporate Information, Location and Competitors
Table 13. PRA Health Sciences Clinical Trials of Drugs and Vaccines Major Business
Table 14. PRA Health Sciences Clinical Trials of Drugs and Vaccines Total Revenue (USD Million) (2018-2019)
Table 15. PRA Health Sciences SWOT Analysis
Table 16. PRA Health Sciences Clinical Trials of Drugs and Vaccines Product and Solutions
Table 17. PRA Health Sciences Clinical Trials of Drugs and Vaccines Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 18. ICON Plc Corporate Information, Location and Competitors
Table 19. ICON Plc Clinical Trials of Drugs and Vaccines Major Business
Table 20. ICON Plc Clinical Trials of Drugs and Vaccines Total Revenue (USD Million) (2017-2018)
Table 21. ICON Plc SWOT Analysis
Table 22. ICON Plc Clinical Trials of Drugs and Vaccines Product and Solutions
Table 23. ICON Plc Clinical Trials of Drugs and Vaccines Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 24. Paraxel International Corporation Corporate Information, Location and Competitors
Table 25. Paraxel International Corporation Clinical Trials of Drugs and Vaccines Major Business
Table 26. Paraxel International Corporation Clinical Trials of Drugs and Vaccines Total Revenue (USD Million) (2017-2018)
Table 27. Paraxel International Corporation SWOT Analysis
Table 28. Paraxel International Corporation Clinical Trials of Drugs and Vaccines Product and Solutions
Table 29. Paraxel International Corporation Clinical Trials of Drugs and Vaccines Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 30. Wuxi AppTec Inc. Corporate Information, Location and Competitors
Table 31. Wuxi AppTec Inc. Clinical Trials of Drugs and Vaccines Major Business
Table 32. Wuxi AppTec Inc. Clinical Trials of Drugs and Vaccines Total Revenue (USD Million) (2017-2018)
Table 33. Wuxi AppTec Inc. SWOT Analysis
Table 34. Wuxi AppTec Inc. Clinical Trials of Drugs and Vaccines Product and Solutions
Table 35. Wuxi AppTec Inc. Clinical Trials of Drugs and Vaccines Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 36. Charles River Laboratories Corporate Information, Location and Competitors
Table 37. Charles River Laboratories Clinical Trials of Drugs and Vaccines Major Business
Table 38. Charles River Laboratories Clinical Trials of Drugs and Vaccines Total Revenue (USD Million) (2017-2018)
Table 39. Charles River Laboratories SWOT Analysis
Table 40. Charles River Laboratories Clinical Trials of Drugs and Vaccines Product and Solutions
Table 41. Charles River Laboratories Clinical Trials of Drugs and Vaccines Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 42. INC Research Corporate Information, Location and Competitors
Table 43. INC Research Clinical Trials of Drugs and Vaccines Major Business
Table 44. INC Research Clinical Trials of Drugs and Vaccines Total Revenue (USD Million) (2017-2018)
Table 45. INC Research SWOT Analysis
Table 46. INC Research Clinical Trials of Drugs and Vaccines Product and Solutions
Table 47. INC Research Clinical Trials of Drugs and Vaccines Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 48. Pharmaceutical Product Development, LLC Corporate Information, Location and Competitors
Table 49. Pharmaceutical Product Development, LLC Clinical Trials of Drugs and Vaccines Major Business
Table 50. Pharmaceutical Product Development, LLC Clinical Trials of Drugs and Vaccines Total Revenue (USD Million) (2017-2018)
Table 51. Pharmaceutical Product Development, LLC SWOT Analysis
Table 52. Pharmaceutical Product Development, LLC Clinical Trials of Drugs and Vaccines Product and Solutions
Table 53. Pharmaceutical Product Development, LLC Clinical Trials of Drugs and Vaccines Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 54. SGS SA Corporate Information, Location and Competitors
Table 55. SGS SA Clinical Trials of Drugs and Vaccines Major Business
Table 56. SGS SA Clinical Trials of Drugs and Vaccines Total Revenue (USD Million) (2017-2018)
Table 57. SGS SA SWOT Analysis
Table 58. SGS SA Clinical Trials of Drugs and Vaccines Product and Solutions
Table 59. SGS SA Clinical Trials of Drugs and Vaccines Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 60. Chiltern International Ltd. Corporate Information, Location and Competitors
Table 61. Chiltern International Ltd. Clinical Trials of Drugs and Vaccines Major Business
Table 62. Chiltern International Ltd. Clinical Trials of Drugs and Vaccines Total Revenue (USD Million) (2017-2018)
Table 63. Chiltern International Ltd. SWOT Analysis
Table 64. Chiltern International Ltd. Clinical Trials of Drugs and Vaccines Product and Solutions
Table 65. Chiltern International Ltd. Clinical Trials of Drugs and Vaccines Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 66. Global Clinical Trials of Drugs and Vaccines Revenue (Million USD) by Players (2015-2020)
Table 67. Global Clinical Trials of Drugs and Vaccines Revenue Share by Players (2015-2020)
Table 68. Global Clinical Trials of Drugs and Vaccines Revenue (Million USD) by Regions (2015-2020)
Table 69. Global Clinical Trials of Drugs and Vaccines Revenue Market Share by Regions (2015-2020)
Table 70. North America Clinical Trials of Drugs and Vaccines Revenue by Countries (2015-2020)
Table 71. North America Clinical Trials of Drugs and Vaccines Revenue Market Share by Countries (2015-2020)
Table 72. Europe Clinical Trials of Drugs and Vaccines Revenue (Million USD) by Countries (2015-2020)
Table 73. Asia-Pacific Clinical Trials of Drugs and Vaccines Revenue (Million USD) by Countries (2015-2020)
Table 74. South America Clinical Trials of Drugs and Vaccines Revenue by Countries (2015-2020)
Table 75. South America Clinical Trials of Drugs and Vaccines Revenue Market Share by Countries (2015-2020)
Table 76. Middle East and Africa Clinical Trials of Drugs and Vaccines Revenue (Million USD) by Countries (2015-2020)
Table 77. Middle East and Africa Clinical Trials of Drugs and Vaccines Revenue Market Share by Countries (2015-2020)
Table 78. Global Clinical Trials of Drugs and Vaccines Revenue (Million USD) by Type (2015-2020)
Table 79. Global Clinical Trials of Drugs and Vaccines Revenue Share by Type (2015-2020)
Table 80. Global Clinical Trials of Drugs and Vaccines Revenue Forecast by Type (2021-2025)
Table 81. Global Clinical Trials of Drugs and Vaccines Revenue by Application (2015-2020)
Table 82. Global Clinical Trials of Drugs and Vaccines Revenue Share by Application (2015-2020)
Table 83. Global Clinical Trials of Drugs and Vaccines Revenue Forecast by Application (2021-2025)
Table 84. Global Clinical Trials of Drugs and Vaccines Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Clinical Trials of Drugs and Vaccines Picture
Figure 2. Global Clinical Trials of Drugs and Vaccines Revenue Market Share by Type in 2019
Figure 3. Phase I Picture
Figure 4. Phase II Picture
Figure 5. Phase III Picture
Figure 6. Phase IV Picture
Figure 7. Clinical Trials of Drugs and Vaccines Revenue Market Share by Application in 2019
Figure 8. Pharmaceutical Industry Picture
Figure 9. Hospital Picture
Figure 10. Laboratory Picture
Figure 11. Other Picture
Figure 12. Global Clinical Trials of Drugs and Vaccines Revenue (USD Million) and Growth Rate (2015-2025)
Figure 13. North America Clinical Trials of Drugs and Vaccines Revenue (Million USD) and Growth Rate (2015-2025)
Figure 14. Europe Clinical Trials of Drugs and Vaccines Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. Asia-Pacific Clinical Trials of Drugs and Vaccines Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. South America Clinical Trials of Drugs and Vaccines Revenue (Million USD) and Growth Rate (2015-2025)
Figure 17. Middle East and Africa Clinical Trials of Drugs and Vaccines Revenue (Million USD) and Growth Rate (2015-2025)
Figure 18. Global Clinical Trials of Drugs and Vaccines Revenue (Million USD) and Growth Rate (2015-2025)
Figure 19. Global Clinical Trials of Drugs and Vaccines Revenue Share by Players in 2019
Figure 20. Global Top 5 Players Clinical Trials of Drugs and Vaccines Revenue Market Share in 2019
Figure 21. Global Top 10 Players Clinical Trials of Drugs and Vaccines Revenue Market Share in 2019
Figure 22. Key Players Market Share Trend
Figure 23. Global Clinical Trials of Drugs and Vaccines Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 24. Global Clinical Trials of Drugs and Vaccines Revenue Market Share by Regions (2015-2020)
Figure 25. Global Clinical Trials of Drugs and Vaccines Revenue Market Share by Regions in 2018
Figure 26. North America Clinical Trials of Drugs and Vaccines Revenue and Growth Rate (2015-2020)
Figure 27. Europe Clinical Trials of Drugs and Vaccines Revenue and Growth Rate (2015-2020)
Figure 28. Asia-Pacific Clinical Trials of Drugs and Vaccines Revenue and Growth Rate (2015-2020)
Figure 29. South America Clinical Trials of Drugs and Vaccines Revenue and Growth Rate (2015-2020)
Figure 30. Middle East and Africa Clinical Trials of Drugs and Vaccines Revenue and Growth Rate (2015-2020)
Figure 31. North America Clinical Trials of Drugs and Vaccines Revenue Market Share by Countries (2015-2020)
Figure 32. North America Clinical Trials of Drugs and Vaccines Revenue Market Share by Countries in 2019
Figure 33. USA Clinical Trials of Drugs and Vaccines Revenue and Growth Rate (2015-2020)
Figure 34. Canada Clinical Trials of Drugs and Vaccines Revenue and Growth Rate (2015-2020)
Figure 35. Mexico Clinical Trials of Drugs and Vaccines Revenue and Growth Rate (2015-2020)
Figure 36. Europe Clinical Trials of Drugs and Vaccines Revenue Market Share by Countries (2015-2020)
Figure 37. Europe Clinical Trials of Drugs and Vaccines Revenue Market Share by Countries in 2019
Figure 38. Germany Clinical Trials of Drugs and Vaccines Revenue and Growth Rate (2015-2020)
Figure 39. UK Clinical Trials of Drugs and Vaccines Revenue and Growth Rate (2015-2020)
Figure 40. France Clinical Trials of Drugs and Vaccines Revenue and Growth Rate (2015-2020)
Figure 41. Russia Clinical Trials of Drugs and Vaccines Revenue and Growth Rate (2015-2020)
Figure 42. Italy Clinical Trials of Drugs and Vaccines Revenue and Growth Rate (2015-2020)
Figure 43. Asia-Pacific Clinical Trials of Drugs and Vaccines Revenue Market Share by Countries (2015-2020)
Figure 44. Asia-Pacific Clinical Trials of Drugs and Vaccines Revenue Market Share by Countries in 2019
Figure 45. China Clinical Trials of Drugs and Vaccines Revenue and Growth Rate (2015-2020)
Figure 46. Japan Clinical Trials of Drugs and Vaccines Revenue and Growth Rate (2015-2020)
Figure 47. Korea Clinical Trials of Drugs and Vaccines Revenue and Growth Rate (2015-2020)
Figure 48. India Clinical Trials of Drugs and Vaccines Revenue and Growth Rate (2015-2020)
Figure 49. Southeast Asia Clinical Trials of Drugs and Vaccines Revenue and Growth Rate (2015-2020)
Figure 50. South America Clinical Trials of Drugs and Vaccines Revenue Market Share by Countries (2015-2020)
Figure 51. South America Clinical Trials of Drugs and Vaccines Revenue Market Share by Countries in 2019
Figure 52. Brazil Clinical Trials of Drugs and Vaccines Revenue and Growth Rate (2015-2020)
Figure 53. Argentina Clinical Trials of Drugs and Vaccines Revenue and Growth Rate (2015-2020)
Figure 54. Middle East and Africa Clinical Trials of Drugs and Vaccines Revenue Market Share by Countries (2015-2020)
Figure 55. Middle East and Africa Clinical Trials of Drugs and Vaccines Revenue Market Share by Countries in 2019
Figure 56. Saudi Arabia Clinical Trials of Drugs and Vaccines Revenue and Growth Rate (2015-2020)
Figure 57. UAE Clinical Trials of Drugs and Vaccines Revenue and Growth Rate (2015-2020)
Figure 58. Egypt Clinical Trials of Drugs and Vaccines Revenue and Growth Rate (2015-2020)
Figure 59. South Africa Clinical Trials of Drugs and Vaccines Revenue and Growth Rate (2015-2020)
Figure 60. Global Clinical Trials of Drugs and Vaccines Revenue Share by Type (2015-2020)
Figure 61. Global Clinical Trials of Drugs and Vaccines Revenue Share by Type in 2019
Figure 62. Global Clinical Trials of Drugs and Vaccines Market Share Forecast by Type (2021-2025)
Figure 63. Global Phase I Revenue Growth Rate (2015-2020)
Figure 64. Global Phase II Revenue Growth Rate (2015-2020)
Figure 65. Global Phase III Revenue Growth Rate (2015-2020)
Figure 66. Global Phase IV Revenue Growth Rate (2015-2020)
Figure 67. Global Clinical Trials of Drugs and Vaccines Revenue Share by Application (2015-2020)
Figure 68. Global Clinical Trials of Drugs and Vaccines Revenue Share by Application in 2019
Figure 69. Global Clinical Trials of Drugs and Vaccines Market Share Forecast by Application (2021-2025)
Figure 70. Global Pharmaceutical Industry Revenue Growth Rate (2015-2020)
Figure 71. Global Hospital Revenue Growth Rate (2015-2020)
Figure 72. Global Laboratory Revenue Growth Rate (2015-2020)
Figure 73. Global Other Revenue Growth Rate (2015-2020)
Figure 74. Global Clinical Trials of Drugs and Vaccines Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 75. Global Clinical Trials of Drugs and Vaccines Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 76. Global Clinical Trials of Drugs and Vaccines Revenue Market Share Forecast by Regions (2021-2025)
Figure 77. North America Clinical Trials of Drugs and Vaccines Revenue Market Forecast (2021-2025)
Figure 78. Europe Clinical Trials of Drugs and Vaccines Revenue Market Forecast (2021-2025)
Figure 79. Asia-Pacific Clinical Trials of Drugs and Vaccines Revenue Market Forecast (2021-2025)
Figure 80. South America Clinical Trials of Drugs and Vaccines Revenue Market Forecast (2021-2025)
Figure 81. Middle East and Africa Clinical Trials of Drugs and Vaccines Revenue Market Forecast (2021-2025)
Figure 82. Sales Channel: Direct Channel vs Indirect Channel
臨床試験用消耗品の世界市場2020年：メーカー別、地域別、種類・用途別 Market Overview The global Clinical Trials Consumables market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 5.2% in the forecast period of 2020 to 2025 and will expected to reach USD 1144.1 million by 2025, from USD 934.3 million in 2019. The Clinical …- ライフサイエンス受託研究アウトソーシングの世界市場2020年：企業別、地域別、種類・用途別 Market Overview The Life Sciences Contract Research Outsourcing market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, val…
- mRNAワクチンの世界市場2020年：企業別、地域別、種類・用途別 Market Overview The mRNA Vaccines market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade r…
- HIVワクチンの世界市場2020年：企業別、地域別、種類・用途別 Market Overview The global HIV Vaccines market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The HIV Vaccines market report provi…
- DPTワクチンの世界市場2020年：メーカー別、地域別、種類・用途別 Market Overview The global DPT Vaccines market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The DPT Vaccines market report provi…